Skip to content
Search
Close
SHOP
  • News
  • Analysis
  • Commentary
  • Essays
  • Interviews
  • Reviews
  • Tributes
  • Media
Menu
  • News
  • Analysis
  • Commentary
  • Essays
  • Interviews
  • Reviews
  • Tributes
  • Media
  • NEWS

Two-Strain COVID Vaccines Could be Available for Fall Booster Campaign

Vaccines targeting the BA.1, BA.4, and BA.5 strains of the Omicron variant are in developmental stages, but the European Medicines Agency is not certain all will be approved by September.
  • Bridget Ryder
  • — July 17, 2022
Vaccines targeting the BA.1, BA.4, and BA.5 strains of the Omicron variant are in developmental stages, but the European Medicines Agency is not certain all will be approved by September.
  • Bridget Ryder
  • — July 17, 2022

The European Medicines Agency (EMA) anticipates that new, two-strain vaccines against COVID-19 could be ready in September, Reuters reports.

mRNA vaccines made to combat both the original Wuhan strain of the virus and various strains of the Omicron variant are undergoing development by an alliance between Moderna (MRNA.O) and the BioNTech-Pfizer (22UAy.DE).

Viruses naturally mutate as they circulate through populations, and vaccination science has long recognized the necessity of updating vaccines to match the most dominant strains in the population and make the vaccines more effective. New flu vaccines, for example, are developed annually using new strains of the virus. These are called bivalent vaccines. 

A sub-strain of the Omicron variant of the COVID-19 is the most dominant COVID-19 variant presently circulating.

“We project that by the end of this month the BA.5 sublineage will be the dominant variant in most of the EU countries,” Pierre Delsaux, the director EU’s Health Emergency Preparedness and Response Authority, told members of the European Parliament in a hearing, according to Reuters.

Vaccines targeting the BA.1, BA.4, and BA.5 strains of the Omicron variant are in developmental stages, but the EMA is not certain all will be approved by September. 

“Whatever bivalent vaccine is finally… available in Europe, it will be a good vaccine, it will be a better vaccine, even against BA.4/BA.5,” Delsaux said.

COVID-19 cases and hospitalisation rose in June, but not alarmingly. 

On July 11, the EMA agencies issued a recommendation for booster shots for those between 60 and 79 and for those with other risk factors. 

Bridget Ryder is a news writer for The European Conservative. She holds degrees in Spanish and Catholic Studies.
  • Tags: COVID-19, European Medicines Agency, vaccines

READ NEXT

EU Hopes To Reform Electricity Market by April

Bridget Ryder February 4, 2023

European Commission: No Reason To Scrap Qatar Aviation Deal

Tamás Orbán February 4, 2023

France: New Day of Mobilisation Against Pension Reform

Hélène de Lauzun February 4, 2023

IMPRESSUM

SUBSCRIPTION

LOG IN

PRIVACY POLICY

CONTACT

[email protected]

© The European Conservative 2023

  • Impressum
  • Privacy Policy
  • General Privacy Policy
  • Terms & Conditions

Made by DIGITALHERO

Issue 25, Winter 2023

  • News
  • Analysis
  • Commentary
  • Essays
  • Interviews
  • Reviews
  • Tributes
  • Media
Menu
  • News
  • Analysis
  • Commentary
  • Essays
  • Interviews
  • Reviews
  • Tributes
  • Media
Search

About

SHOP

JOBS & VACANCIES

Login